Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

American Journal of Ophthalmology

Volumn 158, Issue 1, 2014, Pages

  Kim, Benjamin J ^a   Ying, Gui Shuang ^a   Huang, Jiayan ^a   Levy, Nicole E ^a   Maguire, Maureen G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRY EYE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETINAL THICKNESS; SPORADIC VISION LOSS; SUBRETINAL FLUID; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COHORT STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION DISORDERS; VISION TESTS; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84902543837     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2014.04.004     Document Type: Article

References (27)

1. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial Arch Ophthalmol 100 6 1982 912 918
2. N.M. Bressler Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2 Arch Ophthalmol 119 2 2001 198 207 (Pubitemid 32147926)
3. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr., M. Feinsod, D.R. Guyer VISiON Clinical Trial Group Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 27 2004 2805 2816 (Pubitemid 40051904)
4. P.J. Rosenfeld, D.M. Brown, and J.S. Heier et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431 (Pubitemid 44511557)
5. D.M. Brown, P.K. Kaiser, and M. Michels et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444 (Pubitemid 44511558)
6. Comparison of Age-related Macular Degeneration Treatments Trials Research Group D.F. Martin, and M.G. Maguire et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398
7. J.S. Heier, D.M. Brown, and V. Chong et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 12 2012 2537 2548
8. D.W. Blackhurst, and M.G. Maguire Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study Group Retina 9 3 1989 163 169 (Pubitemid 19262177)
9. R.W. Beck, P.S. Moke, and A.H. Turpin et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol Am J Ophthalmol 135 2 2003 194 205 (Pubitemid 36151797)
10. B.W. Rovner, R.J. Casten, R.W. Massof, B.E. Leiby, W.S. Tasman Wills Eye AMD Study Psychological and cognitive determinants of vision function in age-related macular degeneration Arch Ophthalmol 129 7 2011 885 890
11. B.W. Rovner, R.J. Casten, and W.S. Tasman Effect of depression on vision function in age-related macular degeneration Arch Ophthalmol 120 8 2002 1041 1044 (Pubitemid 34856071)
12. X. Zhang, K.M. Bullard, and M.F. Cotch et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008 JAMA Ophthalmol 131 5 2013 573 581
13. I. Carriere, C. Delcourt, and V. Daien et al. A prospective study of the bi-directional association between vision loss and depression in the elderly J Affect Disord 151 1 2013 164 170
14. R.A. Armstrong Visual symptoms in Parkinson's disease Parkinsons Dis 2011 2011 908306
15. E. Kirby, S. Bandelow, and E. Hogervorst Visual impairment in Alzheimer's disease: a critical review J Alzheimers Dis 21 1 2010 15 34
16. G.R. Jackson, and C. Owsley Visual dysfunction, neurodegenerative diseases, and aging Neurol Clin 21 3 2003 709 728 (Pubitemid 36754063)
17. M.M. Moschos, I. Markopoulos, and I. Chatziralli et al. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease Curr Alzheimer Res 9 7 2012 782 788
18. S. Wolf, F.G. Holz, and J.F. Korobelnik et al. Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR Br J Ophthalmol 95 12 2011 1713 1718
19. C.R. Group, D.F. Martin, and M.G. Maguire et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
20. Ying GS, Kim BJ, Maguire MG, et al. Sustained visual acuity loss in the Comparison of AMD Treatments Trials (CATT). JAMA Ophthalmol (forthcoming).
21. G.S. Ying, J. Huang, and M.G. Maguire et al. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ophthalmology 120 1 2013 122 129
22. J.E. Grunwald, E. Daniel, and G.S. Ying et al. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology 119 8 2012 1634 1641
23. F.C. DeCroos, C.A. Toth, and S.S. Stinnett et al. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials Ophthalmology 119 12 2012 2549 2557
24. D.L. Groll, T. To, C. Bombardier, and J.G. Wright The development of a comorbidity index with physical function as the outcome J Clin Epidemiol 58 6 2005 595 602 (Pubitemid 40692725)
25. R.A. Kenny, J. Bhangu, and B.L. King-Kallimanis Epidemiology of syncope/collapse in younger and older Western patient populations Prog Cardiovasc Dis 55 4 2013 357 363
26. S. Khera, C. Palaniswamy, and W.S. Aronow et al. Predictors of mortality, rehospitalization for syncope, and cardiac syncope in 352 consecutive elderly patients with syncope J Am Med Dir Assoc 14 5 2013 326 330
27. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 Arch Ophthalmol 119 10 2001 1417 1436